North Peak Capital Management, LLC - 24 Feb 2026 SCHEDULE 13G Report for Haemonetics Corporation Common stock, $.01 par value per share (HAE)

Filing Manager
North Peak Capital Management, LLC
Reporting Manager
North Peak Capital Management, LLC
Security
Haemonetics Corporation Common stock, $.01 par value per share
Symbol
HAE
Shares outstanding
46,480,294 shares
Disclosed Ownership
2,370,495 shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
03 Mar 2026, 18:24:41 UTC
Date of event
24 Feb 2026
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
North Peak Capital Management, LLC 5.1% 2,370,495 0 1,882,037 /s/ Jeremy Kahan Jeremy Kahan/Managing Member
North Peak Capital GP, LLC 4% 1,882,037 0 1,882,037 /s/ Jeremy Kahan Jeremy Kahan/Manager
North Peak Capital Partners, LP 0.3% 135,354 0 135,354 /s/ Jeremy Kahan Jeremy Kahan/Manager of North Peak Capital GP, LLC, its General Partner
North Peak Capital Partners II, LP 2.1% 993,566 0 993,566 /s/ Jeremy Kahan Jeremy Kahan/Manager of North Peak Capital GP, LLC, its General Partner
North Peak Capital Alpha Fund, LP 1.4% 651,061 0 651,061 /s/ Jeremy Kahan Jeremy Kahan/Manager of North Peak Capital GP, LLC, its General Partner
North Peak Capital Ultra Fund, LP 0.2% 102,056 0 102,056 /s/ Jeremy Kahan Jeremy Kahan/Manager of North Peak Capital GP, LLC, its General Partner
Michael Kevin Kahan 4% 1,882,037 0 1,882,037 /s/ Michael Kahan Michael Kahan
Jeremy Steven Kahan 4% 1,882,037 0 1,882,037 /s/ Jeremy Kahan Jeremy Kahan